Surgeons need to adapt to evolving strategies for hepatocellular carcinoma (HCC) that prioritize biological insights and dynamic eligibility criteria. Curative treatments offer optimal long-term outcomes, yet 5-year recurrence rates remain at about 70%. New methods in immunogenomic profiling and liquid biopsy enhance patient selection beyond traditional staging. These advances enable personalized surgical strategies and improve […]
Category: General Surgery
Effective Oral Care Cuts Surgical Site Infections
Perioperative oral management significantly reduces surgical site infections (SSIs) and shortens hospital stays. Oral care interventions lowered SSI risk by 36% in experimental studies (RR=0.64) and 51% in observational studies (OR=0.49). Modest effects were noted in patients with cardiovascular disease (OR=0.72) and non-oncology patients (OR=0.66). Implement tailored oral management plans to optimize preoperative care. Protocols […]
Postoperative Analgesia: Emphasizing Oral Over IV
A study reveals a major disconnect in postoperative analgesia practices, highlighting a need for surgeons to consider oral routes for efficiency and cost savings. Intravenous (IV) analgesia was used in 86% of non-opioid patients and 39% for opioids, while the oral route was utilized in only 1%. Transitioning to oral analgesia can cut costs per […]
Guided Classification Improves Outcomes in Pancreatic Surgery
A new intraoperative classification system enhances pancreatic surgery for benign and low-grade tumors. 122 patients underwent robotic resections with IPDECT; type I defects had a 10.6% overall complication rate including 8.5% for postoperative pancreatic fistula. Type IV defects had longer operations (mean 127.6 min) yet only 5.9% complications. Standardizing decision-making may enhance patient outcomes and […]
NSAID Timing Impacts Early Leak Risk in Rectal Surgery
Early use of NSAIDs post-proctectomy increases the risk of early anastomotic leaks. 8.7% overall rate of anastomotic leaks, with early NSAID use linked to higher rates (7.7% vs. 4.7%, p = 0.030). Non-selective NSAIDs and multiple doses significantly heighten early leak risk (OR 1.717, p = 0.012; OR 1.687, p = 0.016). Consider timing and […]
Single-port robotic esophagectomy shows promise
Single-port subcostal robotic esophagectomy is safe and feasible for esophageal cancer, with significant benefits for patient recovery. R0 resection achieved in 100% of cases; mean lymph node yield was 30. No intraoperative complications; mean total operative time was 324 minutes. Postoperative complications included 8% pneumonia and 8% anastomotic leaks, all managed endoscopically. This technique supports […]
Staged Resection Outperforms Simultaneous Strategy for Liver Metastases
Staged resection is safer and offers better outcomes than simultaneous resection for patients with initially unresectable colorectal liver metastases. Staged resection had lower overall complications (35.8% vs. 48.9%, p=0.014) and major complications (14.8% vs. 24.1%, p=0.027). Staged resection significantly improved relapse-free survival (HR=0.780, p=0.030) and liver-specific survival (HR=0.737, p=0.011). Adopting staged resection could enhance surgical […]
Revolutionizing Diastasis Recti Treatment
Postpartum diastasis recti affects up to 60% of women, impacting recovery and quality of life. AI-enhanced ultrasounds exceed traditional imaging with an accuracy score of 85.93%. Laparoscopic “slim-mesh” repairs show recurrence rates under 10%, outperforming open surgery. Implementing precision medicine could tailor interventions based on individual patient profiles. Intelligent rehab systems can effectively reduce inter-rectus […]
Early-Onset Colorectal Cancer: New Insights on Lymph Node Metastasis
Understanding lymph node metastasis in early-onset colorectal cancer is crucial for surgical decision-making and patient management. Early-onset patients show more aggressive tumor features vs. late-onset: larger size, poorer differentiation, and higher lymphovascular invasion rates. Key predictors for lymph node metastasis include elevated CA19-9, T3/T4 stage, nerve invasion, and lymphovascular invasion, with odds ratios over 2.4 […]
Attrition Rates High in Neoadjuvant Therapy for Pancreatic Cancer
High attrition during neoadjuvant therapy (NAT) complicates surgical candidacy for localized pancreatic cancer, affecting patient outcomes. Out of 427 patients receiving NAT, 57% did not proceed to pancreatectomy due to disease progression (21%) and persistent inoperability (22%). Resectable patients had an attrition rate of 23%, compared to 44% for borderline resectable and 73% for locally […]